Control group:Routine treatment (Pure western medicine): Lopinavir-ritonavir tablet combined with recombinant human interferon alpha 2b injection

2 trials

Sponsors

The 5th Medical Center Chinese PLA General Hospital

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)

Active, not recruitingITMCTR2000003046

The 5th Medical Center Chinese PLA General HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-25Updated: 2023-02-20

Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)

Active, not recruitingChiCTR2000030166

The 5th Medical Center Chinese PLA General HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-25Updated: 2020-02-25